Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125378402 | 12537840 | 2 | F | 20160706 | 20160707 | 20160720 | EXP | AU-VALIDUS PHARMACEUTICALS LLC-AU-2016VAL002202 | VALIDUS | 0.00 | Y | 0.00000 | 20160720 | MD | AU | AU |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125378402 | 12537840 | 1 | PS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Unknown | 12.5 MG, UNK | U | 17963 | 12.5 | MG | |||||||
125378402 | 12537840 | 2 | SS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | U | 17963 | |||||||||||
125378402 | 12537840 | 3 | SS | GALVUMET | METFORMIN HYDROCHLORIDEVILDAGLIPTIN | 1 | UNK | U | 0 | ||||||||||
125378402 | 12537840 | 4 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
125378402 | 12537840 | 5 | C | LATUDA | LURASIDONE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
125378402 | 12537840 | 6 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | UNK | U | 0 | ||||||||||
125378402 | 12537840 | 7 | C | EPILIM | VALPROATE SODIUM | 1 | UNK | U | 0 | ||||||||||
125378402 | 12537840 | 8 | C | ROSUVASTATIN. | ROSUVASTATIN | 1 | UNK | U | 0 | ||||||||||
125378402 | 12537840 | 9 | C | EUTROXSIG | LEVOTHYROXINE SODIUM | 1 | UNK | U | 0 | ||||||||||
125378402 | 12537840 | 10 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | UNK | U | 0 | INHALER | |||||||||
125378402 | 12537840 | 11 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | U | 0 | ||||||||||
125378402 | 12537840 | 12 | C | ASPIRIN /00346701/ | ASCORBIC ACIDASPIRIN | 1 | UNK | U | 0 | ||||||||||
125378402 | 12537840 | 13 | C | VITAMINS WITH MINERALS | MINERALSVITAMINS | 1 | UNK | U | 0 | ||||||||||
125378402 | 12537840 | 14 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | UNK | U | 0 | ||||||||||
125378402 | 12537840 | 15 | C | COD LIVER OIL | COD LIVER OIL | 1 | UNK | U | 0 | ||||||||||
125378402 | 12537840 | 16 | C | PANADOL | ACETAMINOPHEN | 1 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125378402 | 12537840 | 1 | Cardiac disorder |
125378402 | 12537840 | 2 | Hypertension |
125378402 | 12537840 | 3 | Product used for unknown indication |
125378402 | 12537840 | 4 | Product used for unknown indication |
125378402 | 12537840 | 5 | Product used for unknown indication |
125378402 | 12537840 | 6 | Product used for unknown indication |
125378402 | 12537840 | 7 | Product used for unknown indication |
125378402 | 12537840 | 8 | Product used for unknown indication |
125378402 | 12537840 | 9 | Product used for unknown indication |
125378402 | 12537840 | 10 | Product used for unknown indication |
125378402 | 12537840 | 11 | Product used for unknown indication |
125378402 | 12537840 | 12 | Product used for unknown indication |
125378402 | 12537840 | 13 | Product used for unknown indication |
125378402 | 12537840 | 14 | Product used for unknown indication |
125378402 | 12537840 | 15 | Product used for unknown indication |
125378402 | 12537840 | 16 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125378402 | 12537840 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125378402 | 12537840 | Acute coronary syndrome | |
125378402 | 12537840 | Asthenia | |
125378402 | 12537840 | Blood pressure increased | |
125378402 | 12537840 | Chest pain | |
125378402 | 12537840 | Cognitive disorder | |
125378402 | 12537840 | Coronary artery disease | |
125378402 | 12537840 | Coronary artery stenosis | |
125378402 | 12537840 | Dyspnoea | |
125378402 | 12537840 | Emphysema | |
125378402 | 12537840 | Osteoarthritis | |
125378402 | 12537840 | Schizophrenia | |
125378402 | 12537840 | Sleep apnoea syndrome | |
125378402 | 12537840 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |